4 terminated, 4 unknown, 2 completed, 1 recruiting. 12 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Terminated 4, Unknown 4, Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 1 | 4 | Terminated 2, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Cystoid Macular Edema: new trials by email Literature Review of Cystoid Macular Edema trials Research Report on Cystoid Macular Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema Dexamethasone - Cystoid Macular Edema | Phase 1 / Phase 2 | Recruiting | Massachusetts Eye and Ear Infirmary | 6 | 2021-03-15 | 2025-11-26 |
| Minocycline Treatment for Cystoid Macular Edema minocycline - Minocycline, Cystoid Macular Edema | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 5 | 2019-01-01 | 2023-04-19 |
| Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema rhNGF 180 µg/ml eye drops solution, vehicle eye drops - Retinitis Pigmentosa, Cystoid Macular Edema | Phase 2 | Completed | Ospedale San Raffaele | 45 | 2015-05-01 | 2017-09-06 |
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection ziv-aflibercept - Neovascularization, Macular Degeneration | Phase 2 | Unknown | Rafic Hariri University Hospital | 100 | 2015-03-01 | 2018-08-29 |
| Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study dexamethasone injection - Retinitis Pigmentosa, Cystoid Macular Edema | Phase 2 | Unknown | Rafic Hariri University Hospital | 50 | 2015-01-01 | 2016-06-20 |
| Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma Ozurdex, Bevacizumab - Macular Edema, Cystoid Macular Edema | Phase 2 | Terminated | Arman Mashayekhi | 6 | 2014-04-01 | 2019-09-03 |
| Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema. Bromfenac (Xibrom), Refresh Plus - Cystoid Macular Edema | Phase 2 | Withdrawn | Johns Hopkins University | 2008-05-01 | 2016-07-04 | |
| Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 58 | 2007-09-01 | 2013-01-23 |
| The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema Pegaptanib Sodium, Control - Cystoid Macular Edema | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 1 | 2006-07-01 | 2008-05-12 |
| Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics Pegaptanib sodium, Control - Cystoid Macular Edema | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 4 | 2006-06-01 | 2008-05-12 |
| Study to Treat Uveitis Associated Macular Edema denufosol tetrasodium (INS37217) Intravitreal Injection - Cystoid Macular Edema, Uveitis | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 15 | 2005-09-01 | 2016-11-29 |
Macular Edema (12) · Retinitis Pigmentosa (2) · Birdshot Chorioretinopathy (1) · Central Serous Chorioretinopathy (1) · Choroidal Neovascularization (1) · Diabetic Retinopathy (1) · Macular Degeneration (1) · Neovascularization, Pathologic (1) · Pars Planitis (1) · Pterygium (1) · Retinal Neovascularization (1) · Retinal Vein Occlusion (1) · Uveal Melanoma (1) · Uveitis (1) · cyclopia sequence (1)
Eye Diseases (12) · Retinal Degeneration (12) · Retinal Diseases (12) · Macular Degeneration (11) · Uveal Diseases (5) · Choroid Diseases (3) · Choroiditis (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Panuveitis (2) · Retinal Dystrophies (2) · Uveitis (2) · Uveitis, Posterior (2) · Autoimmune Diseases (1)
Dexamethasone (2) · pegaptanib (2) · Bevacizumab (1) · Calcium Dobesilate (1) · Interferon alpha-2 (1) · Intravitreal Injections (1) · Minocycline (1) · Ophthalmic Solutions (1) · Prednisone (1) · Triamcinolone Acetonide (1) · aflibercept (1) · bromfenac (1) · cenegermin (1) · denufosol tetrasodium (1)
Johns Hopkins University (3) · Rafic Hariri University Hospital (2) · Arman Mashayekhi (1) · Assistance Publique - Hôpitaux de Paris (1) · Benha University (1) · Massachusetts Eye and Ear Infirmary (1) · Merck Sharp & Dohme LLC (1) · Ospedale San Raffaele (1) · Sun Yat-sen University (1)
United States (5) · China (1) · Egypt (1) · France (1) · Italy (1) · Lebanon (1)
Ahmad M Mansour, MD (1) · Ahmad Mansour, MD (1) · Ahmed A Abdelshafy, MD (1) · Alisa Kim, MD (1) · Amy Schaberg, BSN (1) · Armen Mashayekhi, MD (1) · Diana V. Do, MD (1) · Oliver D. Schein, MD, MPH, MBA (1) · Paolo Rama, MD (1)
PMID 15079763, PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432, PMID 36912792